Study guide

2.1 Postpartum Hemorrhage Etiology (4 T's) & Quantitative Blood Loss (QBL)

C-OBE Obstetric Emergencies Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Maternal Assessment, Risk Stratification & Early Warning Systems

1.1 Pre-Existing Medical, Surgical & Obstetric Comorbidities in Emergency Risk Stratification 1.2 Dynamic Antepartum & Intrapartum Risk Assessment 1.3 Maternal Early Warning Systems (MEWS/MEWT) & Critical Triage Physical Assessment 1.4 Alliance for Innovation on Maternal Health (AIM) Safety Bundles & Emergency Readiness

2 Chapter 2: Obstetric Hemorrhage — Etiology, Assessment & Uterotonics

2.1 Postpartum Hemorrhage Etiology (4 T's) & Quantitative Blood Loss (QBL) 2.2 Uterotonic Pharmacology & Stepwise Administration Protocols 2.3 Tranexamic Acid (TXA) Protocols & Hemorrhage Timing

3 Chapter 3: Obstetric Hemorrhage — Mechanical Interventions, Placental Disorders & Transfusion

3.1 Intrauterine Tamponade Balloons, Compression Sutures & Surgical Hemostasis 3.2 Ectopic Pregnancy, Placenta Previa, Accreta Spectrum (PAS), Abruption & Vasa Previa 3.3 Obstetric DIC, Coagulopathy & Massive Transfusion Protocol (MTP)

4 Chapter 4: Hypertensive Disorders of Pregnancy & Preeclampsia with Severe Features

4.1 Classification & Spectrum of Hypertensive Disorders of Pregnancy 4.2 Preeclampsia with Severe Features: Pathophysiology & End-Organ Damage 4.3 Diagnostic Evaluation, Laboratory Triggers & Fetal Surveillance in Preeclampsia

5 Chapter 5: Hypertensive Crisis, Eclampsia & Magnesium Sulfate Therapy

5.1 Acute Severe Hypertension & First-Line Antihypertensive Protocols 5.2 Eclampsia Recognition, Seizure Management & Airway Protection 5.3 Magnesium Sulfate Neuroprotection/Seizure Prophylaxis Protocols, Monitoring & Toxicity Reversal 5.4 HELLP Syndrome & Hepatic Crisis Management

6 Chapter 6: Maternal Resuscitation, Cardiac Arrest & Perimortem Cesarean

6.1 Maternal ACLS Modifications & Cardiopulmonary Resuscitation Physiology 6.2 Etiologies of Maternal Arrest & Structured Emergency Response 6.3 Perimortem Cesarean Delivery (PMCD / Resuscitative Hysterotomy)

7 Chapter 7: Amniotic Fluid Embolism & Maternal Shock States

7.1 Amniotic Fluid Embolism (AFE): Pathophysiology & Clinical Presentation 7.2 A-OK Protocol, Hemodynamic Support & Critical Care in AFE 7.3 Maternal Shock States: Hemorrhagic, Distributive, Cardiogenic & Obstructive

8 Chapter 8: Acute Intrapartum Delivery Emergencies

8.1 Shoulder Dystocia: Recognition, Timing & Primary HELPERR Sequence 8.2 Advanced Shoulder Dystocia Maneuvers & Neonatal Brachial Plexus Injury Prevention 8.3 Umbilical Cord Prolapse Recognition & Emergent Decompression Protocols

9 Chapter 9: Uterine Inversion, Malpresentation & Obstetric Trauma

9.1 Acute Uterine Inversion: Recognition, Tocolysis & Manual/Surgical Reduction 9.2 Emergency Vaginal Breech Extraction & Head Entrapment Maneuvers 9.3 Maternal Trauma: Primary/Secondary Survey, Placental Abruption & Fetomaternal Hemorrhage

10 Chapter 10: Maternal Sepsis, Intraamniotic Infection & Severe Infections

10.1 Maternal Sepsis: Physiological Criteria, S.O.S. Score & omSOFA 10.2 The Maternal Sepsis Hour-1 Bundle & Fluid/Vasopressor Optimization 10.3 Intraamniotic Infection (Triple I / Chorioamnionitis) & Severe Endometritis 10.4 Severe Pyelonephritis, Maternal Pneumonia & Severe Peripartum Infections

11 Chapter 11: Endocrine, Cardiovascular, Respiratory & Neurologic Emergencies

11.1 Diabetic Ketoacidosis (DKA), Maternal Hypoglycemia & Endocrine Resuscitation in Pregnancy 11.2 Peripartum Cardiomyopathy (PPCM), Acute Heart Failure, Acute Coronary Syndromes & Maternal Arrhythmias 11.3 Status Asthmaticus, Pulmonary Edema & ARDS in Pregnancy 11.4 Status Epilepticus, Acute Stroke & Cerebral Venous Sinus Thrombosis (CVST)

12 Chapter 12: Thromboembolism, Hepatorenal Disorders & Toxicologic Emergencies

12.1 Venous Thromboembolism (DVT/PE) Diagnosis, Treatment & Peripartum Anticoagulation 12.2 Acute Fatty Liver of Pregnancy (AFLP / Swansea Criteria) & Acute Kidney Injury 12.3 Peripartum Substance Overdose, Opioid Toxicity & Naloxone Administration

13 Chapter 13: Obstetric Anesthesia Emergencies & Critical Complications

13.1 High Spinal / Total Spinal Anesthesia & Aspiration Pneumonitis 13.2 Local Anesthetic Systemic Toxicity (LAST) & 20% Lipid Emulsion Rescue Protocol 13.3 Post-Dural Puncture Headache (PDPH), Epidural Hematoma & Abscess 13.4 Malignant Hyperthermia in Obstetric Anesthesia & Dantrolene Protocol

14 Chapter 14: Professional Practice, Team Communication, Debriefing & Health Equity

14.1 Crisis Resource Management (CRM), TeamSTEPPS & Structured Communication 14.2 Multidisciplinary Emergency Debriefing, Morbidity & Mortality, and Systems Learning 14.3 Perinatal Racial/Ethnic Disparities, Implicit Bias Mitigation & Respectful Maternity Care 14.4 Legal, Ethical, Documentation & EMTALA Standards in Obstetric Emergencies

2.1 Postpartum Hemorrhage Etiology (4 T's) & Quantitative Blood Loss (QBL)

Key Takeaways Explain This Topic AI

Postpartum hemorrhage (PPH) is defined as a cumulative blood loss ≥1,000 mL or blood loss accompanied by signs or symptoms of hypovolemia within 24 hours after birth, regardless of the route of delivery.

The underlying etiologies of PPH are categorized by the '4 T's' framework: Tone (uterine atony, 70–80%), Trauma (lacerations, hematomas, rupture, inversion, 20%), Tissue (retained placenta, placenta accreta spectrum, 10%), and Thrombin (coagulopathies, 1%).

Visual estimated blood loss (EBL) notoriously underestimates true obstetric hemorrhage by 33% to 50%; quantitative blood loss (QBL) utilizing gravimetric weighing (1 g = 1 mL) and calibrated volumetric collection drapes is mandatory for early hemorrhage detection.

Persistent bright red vaginal bleeding in the presence of a firm, well-contracted fundus is the classic clinical hallmark of genital tract Trauma (laceration or hematoma) requiring immediate direct surgical visualization.

The CMQCC Staged Hemorrhage Protocol standardizes escalating clinical responses across Stage 0 (active management for all births), Stage 1 (QBL >500 mL vaginal / >1,000 mL cesarean or abnormal vitals), Stage 2 (continued bleeding up to 1,499 mL or non-responsive to 2 uterotonics), and Stage 3 (QBL ≥1,500 mL, massive transfusion activation, or DIC).

Last updated: August 2026

2.1 Postpartum Hemorrhage Etiology (4 T's) & Quantitative Blood Loss (QBL)

Obstetric hemorrhage remains the leading preventable cause of maternal morbidity and mortality worldwide. In the United States, maternal mortality reviews consistently reveal that delayed recognition of excessive blood loss, underestimation of hemorrhage volume, and delayed escalation of standardized multi-step interventions account for the majority of preventable hemorrhage-related deaths. Mastery of the modernized definition of postpartum hemorrhage, rapid identification of underlying etiologies via the 4 T's framework , rigorous execution of Quantitative Blood Loss (QBL) , and strict adherence to Staged Obstetric Hemorrhage Protocols are essential core competencies for inpatient obstetric and emergency clinicians.

1. Modern Consensus Definitions & Epidemiology

Historically, obstetric practice defined postpartum hemorrhage (PPH) using disparate volumetric thresholds: >500 mL following a vaginal delivery and >1,000 mL following a cesarean birth. However, physiological studies demonstrated that average blood loss at normal vaginal delivery frequently approaches 500 mL without adverse sequelae, while visual estimation routinely underreports true loss.

To standardize clinical practice, improve early multidisciplinary recognition, and harmonize emergency triggers, the American College of Obstetricians and Gynecologists (ACOG) , the Society for Maternal-Fetal Medicine (SMFM) , and the ReVITALize initiative updated the definition: +-----------------------------------------------------------------------------+

  • | CONSENSUS DEFINITION OF POSTPARTUM HEMORRHAGE |
  • | |
  • | CUMULATIVE BLOOD LOSS ≥ 1,000 mL |
  • | OR |
  • | BLOOD LOSS ACCOMPANIED BY SIGNS OR SYMPTOMS OF HYPOVOLEMIA |
  • | WITHIN 24 HOURS FOLLOWING THE BIRTH PROCESS |
  • | (REGARDLESS OF THE ROUTE OF DELIVERY: VAGINAL OR CESAREAN) |
  • +-----------------------------------------------------------------------------+
  • Clinical Nuance: The 500–999 mL Warning Threshold

While ≥1,000 mL represents the formal threshold for PPH across all delivery modes, cumulative blood loss between 500 and 999 mL in a vaginal delivery must be regarded as abnormal. It serves as an immediate clinical alert threshold triggering targeted evaluation, vital sign reassessment, bedside nursing vigilance, and active intervention before severe hemodynamic instability ensues.

Primary vs. Secondary Postpartum Hemorrhage

Primary (Early) PPH: Occurs within the first 24 hours after delivery. This accounts for >90% of all maternal hemorrhage deaths and is predominantly driven by uterine atony, genital tract trauma, retained placental tissue, and acute coagulopathy.

Secondary (Late / Delayed) PPH: Occurs between 24 hours and 12 weeks postpartum (most commonly presenting between days 7 and 14). It is primarily caused by retained products of conception (RPOC), subinvolution of the placental implantation site, or postpartum endometritis.

Maternal Hemodynamic Compensation & The "Late Drop"

Maternal plasma volume expands by 40% to 50% during normal pregnancy (an additional 1,200 to 1,600 mL), accompanied by a 20% to 30% increase in red blood cell mass. This profound hypervolemia acts as a physiological buffer against delivery-related blood loss. Consequently, maternal vital signs (blood pressure and heart rate) often remain deceptively normal until 1,500 to 2,000 mL of blood (30% to 40% of total blood volume) has been lost . +-----------------------------------------------------------------------------+

  • | PROGRESSION OF HEMODYNAMIC COMPROMISE IN OBSTETRIC HEMORRHAGE |
  • | |
  • | [CLASS I: <1,000 mL (10-15% Loss)] |
  • | - Heart Rate: Normal / Mild tachycardia (<100 bpm) |
  • | - Blood Pressure: Normal (compensated by systemic vasoconstriction) |
  • | - Clinical Signs: Asymptomatic, mild palpitations |
  • | | |
  • | v |
  • | [CLASS II: 1,000 - 1,499 mL (15-25% Loss)] |
  • | - Heart Rate: Tachycardia (100-120 bpm) |
  • | - Blood Pressure: Normal or slight drop in DBP; narrowed pulse pressure |
  • | - Clinical Signs: Tachypnea, peripheral pallor, delayed capillary refill |
  • | | |
  • | v |
  • | [CLASS III: 1,500 - 1,999 mL (25-35% Loss)] |
  • | - Heart Rate: Marked tachycardia (120-140 bpm) |
  • | - Blood Pressure: OVERT HYPOTENSION (SBP <90 mmHg, MAP <65 mmHg) |
  • | - Clinical Signs: Restlessness, confusion, cold clammy skin, oliguria |
  • | | |
  • | v |
  • | [CLASS IV: ≥2,000 mL (>35% Loss)] |
  • | - Heart Rate: Extreme tachycardia (>140 bpm) or terminal bradycardia |
  • | - Blood Pressure: Profound, unrecordable hypotension |
  • | - Clinical Signs: Lethargy, stupor, anuria, cardiovascular collapse |
  • +-----------------------------------------------------------------------------+

Warning

Tachycardia Precedes Hypotension: In an obstetric patient, resting maternal tachycardia (heart rate > 100–110 bpm) or tachypnea (respiratory rate > 24 breaths/min) is an early, highly sensitive marker of occult hypovolemia. Do NOT wait for systolic hypotension (SBP < 90 mmHg) to activate hemorrhage bundles; hypotension is a late, decompensated finding indicating life-threatening intravascular depletion.

2. The 4 T's Diagnostic Framework of Obstetric Hemorrhage

Systematic clinical investigation of PPH relies on the 4 T's differential framework: Tone , Trauma , Tissue , and Thrombin .

Etiological Category Approximate Incidence Pathophysiology & Key Clinical Features Primary Risk Factors Priority Diagnostic & Therapeutic Actions

Tone (Uterine Atony) 70% – 80% Failure of myometrial smooth muscle contraction; failure to compress spiral arteries. Fundus is soft, boggy, above the umbilicus. Overdistension (multiples, polyhydramnios, macrosomia), chorioamnionitis, high parity, prolonged oxytocin use, halogenated anesthetics, magnesium sulfate. Bimanual uterine massage, bladder catheterization, rapid uterotonic administration, tranexamic acid (TXA), intrauterine balloon/vacuum tamponade.

Trauma (Lacerations & Hematomas) 15% – 20% Structural disruption of cervix, vagina, perineum, or broad ligament; uterine rupture; uterine inversion. Fundus is FIRM and well-contracted with continuous bright red vaginal bleeding. Operative vaginal delivery (forceps, vacuum), precipitous delivery, macrosomia, episiotomy, prior uterine scar (TOLAC). Direct visual speculum inspection under adequate lighting, surgical repair of lacerations, incision/drainage/packing of expanding hematomas, emergency laparotomy.

Tissue (Retained Products / PAS) 10% Retained cotyledons, succenturiate lobes, or Placenta Accreta Spectrum (PAS). Persistent subinvolution, dark bleeding with clots, missing placental cotyledons. Prior cesarean delivery, placenta previa over scar, prior uterine curettage, manual removal of placenta, succenturiate placental lobe. Systematic placental inspection, bedside transabdominal/transvaginal ultrasound, gentle manual uterine exploration, ultrasound-guided curettage, hysterectomy for PAS.

Thrombin (Coagulopathies) 1% – 2% Failure of hemostatic clot formation. Pre-existing (vWD, ITP, hemophilia carrier) or acquired consumptive coagulopathy / DIC. Generalized oozing from puncture sites, petechiae, hematuria. Placental abruption, severe preeclampsia / HELLP syndrome, amniotic fluid embolism (AFE), sepsis, massive fluid resuscitation (dilutional). STAT coagulation panel (PT/INR, aPTT, fibrinogen, D-dimer), rotational thromboelastometry (ROTEM/TEG), Massive Transfusion Protocol (MTP), cryoprecipitate replacement.

  • Deep-Dive Pathophysiology of the 4 T's
  • 1. Tone (Uterine Atony)

During the third stage of labor, normal separation of the placenta exposes hundreds of open uterine spiral arterioles and retroplacental venous sinuses, delivering an astounding blood flow of 600 to 800 mL/min (roughly 15% of maternal cardiac output). Natural hemostasis is almost entirely mechanical: interlacing, crisscross myometrial smooth muscle bundles (the "living ligatures" or ligaturae vivae ) contract vigorously around the penetrating spiral arteries, physically occluding vascular lumens.

When the myometrium fails to contract ( uterine atony ), this massive blood flow pours unchecked into the endometrial cavity. Uterine atony is exacerbated by receptor downregulation (prolonged intrapartum oxytocin infusion desensitizes myometrial oxytocin receptors), intracellular calcium exhaustion, and infection/inflammation (chorioamnionitis stimulates nitric oxide and prostaglandin E2, which induce smooth muscle relaxation).

2. Trauma (Lacerations, Hematomas, Inversion, Rupture)

Genital Tract Lacerations: Cervical lacerations frequently occur at 3 o'clock and 9 o'clock positions following operative vaginal birth or rapid cervical dilatation. Perineal lacerations extending through the anal sphincter complex (3rd and 4th degree) or deep sulcal vaginal tears can lacerate branches of the pudendal or inferior rectal arteries.

Puerperal Hematomas: Classified by anatomical location relative to the pelvic diaphragm:

Vulvar/Vaginal Hematomas: Infralevator collection arising from branches of the internal pudendal artery. Characterized by excruciating unilateral perineal/rectal pressure, tense purple perineal swelling, and inability to void.

Retroperitoneal / Broad Ligament Hematomas: Supralevator collection arising from branches of the uterine or hypogastric artery. Characterized by concealed hemorrhage , sudden maternal hemodynamic collapse, and severe flank/lower back pain with minimal external vaginal bleeding.

Uterine Inversion: The uterine fundus collapses into the endometrial cavity and prolapses through the cervix into the vagina or past the introitus. Classically precipitated by vigorous fundal pressure on an uncontracted uterus or excessive umbilical cord traction before complete placental separation. Triggers profound neurogenic shock (vasovagal collapse) out of proportion to visible blood loss.

Uterine Rupture: Complete disruption of all uterine layers including the visceral peritoneum, occurring primarily in patients undergoing trial of labor after cesarean (TOLAC) or prior transmural myomectomy. Clinical signs include sudden severe localized abdominal pain, loss of fetal station, non-reassuring fetal heart rate tracings (terminal bradycardia), and maternal hypovolemic shock.

3. Tissue (Retained Placental Fragments & Placenta Accreta Spectrum)

Retained Products of Conception (RPOC): Incomplete placental separation or retained succenturiate lobes prevent uniform myometrial contraction. Routine post-delivery examination of both the maternal cotyledons and the fetal membranes (checking for torn vessels traversing membrane edges) is mandatory.

Placenta Accreta Spectrum (PAS): Defective decidua basalis leading to direct invasion of chorionic villi into the myometrium:

Placenta Accreta: Villi attach directly to the myometrial surface without intervening decidua (75–80% of PAS).

Placenta Increta: Villi invade deep into the myometrial wall (15–20% of PAS).

Placenta Percreta: Villi penetrate completely through the myometrium and visceral serosa, often invading the maternal bladder or pelvic sidewall (5% of PAS).

4. Thrombin (Pre-Existing & Consumptive Coagulopathies)

Disseminated Intravascular Coagulation (DIC): In obstetrics, DIC is rapidly triggered by massive release of tissue factor (thromboplastin) into the maternal circulation—most commonly secondary to severe placental abruption , amniotic fluid embolism (AFE) , or septic abortion/chorioamnionitis . This triggers systemic microvascular thrombus formation, rapid consumption of clotting factors and platelets, and explosive hyperfibrinolysis.

Obstetric Hypofibrinogenemia: Plasma fibrinogen in late pregnancy normally rises to 400 to 600 mg/dL . A fibrinogen level < 200 mg/dL in an actively bleeding obstetric patient is a critical red flag indicating advanced consumptive coagulopathy and is an independent predictor of severe maternal morbidity and massive transfusion requirement.

3. Quantitative Blood Loss (QBL) vs. Estimated Blood Loss (EBL)

Visual estimation of blood loss (EBL) relies on subjective visual assessment by clinical staff. Extensive clinical literature demonstrates that EBL underestimates high-volume blood loss by 33% to 50% and overestimates low-volume blood loss . In an emergency, visual estimation creates false reassurance, delaying lifesaving interventions.

Quantitative Blood Loss (QBL) is the standardized, objective, real-time measurement of cumulative blood loss using gravimetric and volumetric tools. +-----------------------------------------------------------------------------+

  • | QUANTITATIVE BLOOD LOSS (QBL) TECHNIQUES |
  • | |
  • | 1. GRAVIMETRIC MEASUREMENT (Weighing) |
  • | - Direct weighing of all blood-soaked sponges, pads, chux, drapes. |
  • | - Standard Physical Constant: 1 gram of weight increase = 1 mL blood. |
  • | - FORMULA: QBL (mL) = [Total Wet Weight (g)] - [Known Dry Weight (g)] |
  • | |
  • | 2. VOLUMETRIC MEASUREMENT (Canisters & Drapes) |
  • | - Calibrated under-buttock collection drapes with graduated markings. |
  • | - Calibrated surgical suction canisters. |
  • | - FORMULA: Suction QBL (mL) = [Total Canister Volume (mL)] |
  • | - [Amniotic Fluid / Irrigation Flush (mL)] |
  • +-----------------------------------------------------------------------------+
  • Practical Execution of Gravimetric QBL

Standardized Reference Card: Every labor room and operating suite maintains a laminated reference card listing the precise dry weight of every standardized supply item (e.g., Laparotomy sponge = 20 g; Chux pad = 50 g; Perineal pad = 15 g; C-section drape = 250 g).

Zeroed Scales: Dedicated digital gram scales are placed at the bedside and inside obstetric operating rooms.

Continuous Weighing: As soon as sponges or pads are removed from the surgical field or perineum, they are placed in clear plastic bags or directly onto the scale.

Accounting for Non-Blood Fluids: During vaginal delivery, the under-buttock drape is placed immediately after the delivery of the infant but before the delivery of the placenta to ensure the initial gush of amniotic fluid is captured and excluded, or measured and subtracted.

4. CMQCC & ACOG Staged Obstetric Hemorrhage Protocols

Standardized staged hemorrhage protocols provide tiered clinical action algorithms based on cumulative QBL thresholds, physiological vital signs, and patient response to therapy.

Stage Trigger Thresholds Team Activation & Nursing Priorities Medical & Surgical Interventions Laboratory & Blood Bank Support

Stage 0 (All Births) Active labor & third stage for every delivery Active management of 3rd stage; continuous QBL measurement; post-delivery fundal assessment and vital signs q15min × 4. Prophylactic Oxytocin (10 U IM or 10–40 U in 1,000 mL IV crystalloid); controlled cord traction; vigorous uterine massage. Routine prenatal Type & Screen on file.

Stage 1 (Alert) Cumulative QBL > 500 mL (vaginal) or > 1,000 mL (cesarean) OR vital signs > 15% abnormal (HR >110, SBP <90). Mobilize primary bedside team; assign dedicated documenter and timer; place second large-bore IV (16–18G); insert Foley catheter with urometer. Bimanual fundal massage; empty bladder; initiate second-line uterotonics (Methergine, Hemabate, or Misoprostol); inspect cervix, vagina, placenta. Verify Type & Screen; warm IV crystalloid infusion; maintain normothermia.

Stage 2 (Active Hemorrhage) Continued bleeding with QBL 1,000 – 1,499 mL OR abnormal vital signs OR non-responsive to 2 uterotonics . Mobilize Obstetric Rapid Response / Hemorrhage Team (OB attending, anesthesia lead, scrub nurse, runner); bring hemorrhage cart to bedside. Administer Tranexamic Acid (TXA) 1 g IV over 10 min (if within 3h of birth); deploy intrauterine balloon tamponade (Bakri) or vacuum tamponade (JADA); prepare OR. STAT Labs: CBC, PT/INR, aPTT, Fibrinogen, Type & Crossmatch (2–4 units); bring 2 units PRBCs to bedside; keep patient warm.

Stage 3 (Critical Shock / MTP) Cumulative QBL ≥ 1,500 mL OR ≥ 2 units PRBCs given OR clinical shock / DIC OR refractory hemorrhage. Activate Massive Transfusion Protocol (MTP) ; mobilize surgical assistants, gynecologic oncology / trauma surgery; dedicate communication coordinator. Immediate transfer to OR; invasive arterial line & central venous access; surgical intervention (B-Lynch sutures, uterine artery ligation, hysterectomy); core warming. Rapid transfusion of balanced blood products ( 1:1:1 ratio of PRBC : FFP : Platelets); transfuse Cryoprecipitate if Fibrinogen <200 mg/dL; serial ABG/lactate/calcium.

Loading diagram... CMQCC Staged Obstetric Hemorrhage Escalation Algorithm